Bile Acid [EPC]

Bile Acid [EPC] was reported 23057 times

Drugs of the Bile Acid [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CFTR GENE MUTATION 19 0.7600
1 BILE ACIDS INCREASED 40 0.2260
2 RESPIRATORY TRACT MALFORMATION 28 0.2105
3 PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA 15 0.1562
4 PULMONARY MALFORMATION 42 0.1197
5 BILIARY CIRRHOSIS 22 0.1095
6 BLOOD ALKALINE PHOSPHATASE ABNORMAL 81 0.0900
7 HAEMOSIDEROSIS 24 0.0896
8 VENOOCCLUSIVE DISEASE 191 0.0762
9 CHOLESTASIS OF PREGNANCY 35 0.0761
10 PRIMARY BILIARY CHOLANGITIS 35 0.0745
11 PARENTERAL NUTRITION 16 0.0693
12 LUNG CYST 27 0.0687
13 BILIARY CIRRHOSIS PRIMARY 22 0.0636
14 VENOOCCLUSIVE LIVER DISEASE 295 0.0597
15 HEPATIC NEOPLASM MALIGNANT 120 0.0566
16 CHOLANGITIS SCLEROSING 100 0.0486
17 DEVICE RELATED BACTERAEMIA 15 0.0484
18 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 43 0.0482
19 PORTAL HYPERTENSIVE GASTROPATHY 26 0.0461
20 VANISHING BILE DUCT SYNDROME 51 0.0457
21 LACTATION DISORDER 22 0.0452
22 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 239 0.0439
23 APLASTIC ANAEMIA 229 0.0438
24 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 26 0.0433
25 POOR SUCKING REFLEX 17 0.0428
26 COMPLICATIONS OF TRANSPLANTED LIVER 14 0.0389
27 BILIARY TRACT INFECTION 24 0.0386
28 DISSEMINATED ASPERGILLOSIS 18 0.0381
29 BILE DUCT STENOSIS 43 0.0359
30 CHOLANGITIS ACUTE 25 0.0331
31 ASPARTATE AMINOTRANSFERASE ABNORMAL 49 0.0322
32 ACUTE GRAFT VERSUS HOST DISEASE 132 0.0288
33 ENGRAFTMENT SYNDROME 17 0.0288
34 LYMPHOCYTE STIMULATION TEST POSITIVE 23 0.0287
35 ENTEROCOCCAL SEPSIS 23 0.0284
36 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 78 0.0282
37 PORTAL HYPERTENSION 86 0.0279
38 HEPATORENAL SYNDROME 46 0.0272
39 GRAFT VERSUS HOST DISEASE IN LIVER 19 0.0265
40 CYSTIC FIBROSIS 146 0.0263
41 LIP PRURITUS 22 0.0257
42 CHOLANGITIS 159 0.0256
43 IRON OVERLOAD 27 0.0250
44 OESOPHAGEAL ACHALASIA 16 0.0248
45 VARICES OESOPHAGEAL 75 0.0248
46 PANCREATITIS RELAPSING 20 0.0244
47 PSEUDOMONAS TEST POSITIVE 20 0.0244
48 LIVER TRANSPLANT 88 0.0242
49 LIVER TRANSPLANT REJECTION 43 0.0239
50 HEPATIC FIBROSIS 81 0.0236
51 ALLERGIC SINUSITIS 20 0.0233
52 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 31 0.0219
53 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 15 0.0209
54 GRAFT VERSUS HOST DISEASE 148 0.0206
55 CHOLANGIOCARCINOMA 30 0.0201
56 HEPATIC ENCEPHALOPATHY 185 0.0198
57 BILE DUCT STONE 61 0.0192
58 BILIARY TRACT DISORDER 25 0.0181
59 OESOPHAGEAL VARICES HAEMORRHAGE 39 0.0179
60 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 38 0.0178
61 POUCHITIS 15 0.0174
62 AXONAL NEUROPATHY 15 0.0172
63 BILIRUBIN CONJUGATED INCREASED 40 0.0171
64 BLOOD AMYLASE INCREASED 29 0.0169
65 KLEBSIELLA BACTERAEMIA 16 0.0168
66 CYTOMEGALOVIRUS TEST POSITIVE 30 0.0168
67 ALANINE AMINOTRANSFERASE ABNORMAL 35 0.0166
68 HEPATIC INFECTION 21 0.0164
69 VASCULAR DEVICE INFECTION 73 0.0161
70 CHRONIC GRAFT VERSUS HOST DISEASE 58 0.0160
71 GALLBLADDER ENLARGEMENT 17 0.0158
72 METASTASES TO SKIN 16 0.0155
73 GRAFT VERSUS HOST DISEASE IN SKIN 34 0.0154
74 PLATELET TRANSFUSION 19 0.0148
75 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 38 0.0147
76 BLOOD BILIRUBIN INCREASED 390 0.0144
77 PNEUMONIA CYTOMEGALOVIRAL 28 0.0144
78 BLOOD BILIRUBIN ABNORMAL 18 0.0141
79 BILIARY OBSTRUCTION 18 0.0139
80 HYPERURICAEMIA 56 0.0136
81 BLOOD ALKALINE PHOSPHATASE INCREASED 338 0.0136
82 PULMONARY FUNCTION TEST DECREASED 58 0.0132
83 ESCHERICHIA BACTERAEMIA 31 0.0132
84 LIVER ABSCESS 42 0.0129
85 HYPERBILIRUBINAEMIA 134 0.0129
86 ASCITES 374 0.0127
87 HEPATIC FAILURE 377 0.0125
88 PNEUMONIA STAPHYLOCOCCAL 24 0.0122
89 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 16 0.0121
90 ADENOVIRUS INFECTION 35 0.0121
91 STEROID DIABETES 18 0.0120
92 HEPATIC CIRRHOSIS 225 0.0120
93 MUCOSAL INFLAMMATION 309 0.0118
94 HEPATIC PAIN 50 0.0117
95 HYPOALBUMINAEMIA 90 0.0116
96 EXPOSURE VIA BREAST MILK 46 0.0115
97 IMMUNE-MEDIATED HEPATIC DISORDER 22 0.0113
98 HEPATIC FUNCTION ABNORMAL 420 0.0112
99 AUTOIMMUNE HEPATITIS 78 0.0112
100 CAPILLARY LEAK SYNDROME 23 0.0111
101 MATERNAL EXPOSURE DURING BREAST FEEDING 45 0.0111
102 BONE MARROW TRANSPLANT 21 0.0111
103 KIDNEY FIBROSIS 19 0.0109
104 PORTAL VEIN THROMBOSIS 35 0.0108
105 AMMONIA INCREASED 55 0.0108
106 CYTOMEGALOVIRUS INFECTION REACTIVATION 47 0.0106
107 CYTOMEGALOVIRUS VIRAEMIA 47 0.0106
108 GASTROENTERITIS NOROVIRUS 14 0.0105
109 BILE DUCT OBSTRUCTION 20 0.0105
110 PRE-ECLAMPSIA 50 0.0105
111 BILIARY DILATATION 15 0.0102
112 POLYMYOSITIS 18 0.0102
113 BLOOD LOSS ANAEMIA 23 0.0101
114 CYSTITIS HAEMORRHAGIC 40 0.0099
115 PARAINFLUENZAE VIRUS INFECTION 15 0.0098
116 IMMUNE-MEDIATED HEPATITIS 20 0.0098
117 ACUTE MYELOID LEUKAEMIA RECURRENT 21 0.0098
118 CHOLESTASIS 187 0.0097
119 SPUTUM INCREASED 21 0.0097
120 GAMMA-GLUTAMYLTRANSFERASE INCREASED 210 0.0095
121 OCULAR ICTERUS 41 0.0094
122 HEPATITIS TOXIC 24 0.0092
123 STEM CELL TRANSPLANT 23 0.0092
124 JAUNDICE 246 0.0091
125 BLOOD ALBUMIN DECREASED 72 0.0091
126 JAUNDICE CHOLESTATIC 32 0.0090
127 HEPATOSPLENOMEGALY 23 0.0090
128 INTRA-ABDOMINAL FLUID COLLECTION 16 0.0089
129 STAPHYLOCOCCAL SEPSIS 44 0.0089
130 HEPATIC MASS 17 0.0088
131 LIVER DISORDER 391 0.0088
132 NORMAL NEWBORN 47 0.0086
133 HYPERAMMONAEMIA 43 0.0086
134 CHOLESTATIC LIVER INJURY 19 0.0085
135 HEPATIC NECROSIS 32 0.0085
136 THROMBOTIC MICROANGIOPATHY 82 0.0084
137 HYPERPHOSPHATAEMIA 18 0.0084
138 DISSEMINATED INTRAVASCULAR COAGULATION 117 0.0083
139 ASPARTATE AMINOTRANSFERASE INCREASED 439 0.0083
140 HEPATIC ENZYME ABNORMAL 41 0.0082
141 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 27 0.0082
142 PSEUDOMEMBRANOUS COLITIS 18 0.0081
143 MULTIPLE ORGAN DYSFUNCTION SYNDROME 225 0.0079
144 HEPATOMEGALY 78 0.0079
145 HUMAN HERPESVIRUS 6 INFECTION 15 0.0079
146 SERUM FERRITIN INCREASED 41 0.0078
147 VARICELLA ZOSTER VIRUS INFECTION 16 0.0077
148 BK VIRUS INFECTION 26 0.0077
149 ALANINE AMINOTRANSFERASE INCREASED 472 0.0077
150 LUNG TRANSPLANT 27 0.0076
151 PSEUDOMONAS INFECTION 65 0.0076
152 DEVICE RELATED SEPSIS 15 0.0074
153 ACUTE LYMPHOCYTIC LEUKAEMIA 21 0.0074
154 FORCED EXPIRATORY VOLUME DECREASED 21 0.0074
155 CYTOKINE RELEASE SYNDROME 147 0.0073
156 FAECAL CALPROTECTIN INCREASED 23 0.0073
157 FAECES PALE 16 0.0072
158 SYSTEMIC CANDIDA 18 0.0072
159 PROCTITIS 20 0.0071
160 PNEUMONIA FUNGAL 28 0.0071
161 BACTERAEMIA 84 0.0071
162 HEPATITIS FULMINANT 21 0.0071
163 CHOLECYSTITIS ACUTE 40 0.0071
164 FEBRILE NEUTROPENIA 465 0.0070
165 TRANSPLANT FAILURE 17 0.0069
166 SPLENOMEGALY 81 0.0069
167 GASTROINTESTINAL ULCER 15 0.0068
168 RHINOVIRUS INFECTION 26 0.0067
169 HYPOPHOSPHATAEMIA 48 0.0065
170 CYTOMEGALOVIRUS INFECTION 107 0.0064
171 DRUG-INDUCED LIVER INJURY 201 0.0064
172 BLOOD LACTATE DEHYDROGENASE INCREASED 101 0.0064
173 ABDOMINAL MASS 17 0.0063
174 BLOOD CULTURE POSITIVE 19 0.0063
175 ASPERGILLUS INFECTION 41 0.0062
176 PHYSICAL DECONDITIONING 16 0.0062
177 STAPHYLOCOCCAL BACTERAEMIA 27 0.0062
178 ENTEROCOCCAL INFECTION 30 0.0062
179 HEPATIC CYTOLYSIS 79 0.0062
180 TOXIC EPIDERMAL NECROLYSIS 94 0.0062
181 HAEMATOLOGICAL INFECTION 15 0.0061
182 HISTIOCYTOSIS HAEMATOPHAGIC 18 0.0061
183 ORGANISING PNEUMONIA 30 0.0060
184 TRANSFUSION 63 0.0060
185 IMMUNE-MEDIATED ENTEROCOLITIS 22 0.0060
186 STEATORRHOEA 16 0.0060
187 PNEUMONIA VIRAL 19 0.0060
188 PULMONARY HAEMORRHAGE 46 0.0059
189 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 56 0.0059
190 LIVER FUNCTION TEST INCREASED 125 0.0058
191 CYTOPENIA 70 0.0057
192 ENTEROCOLITIS 33 0.0057
193 HYPERVOLAEMIA 28 0.0057
194 HEPATITIS CHOLESTATIC 34 0.0056
195 IRON DEFICIENCY ANAEMIA 52 0.0056
196 IRON DEFICIENCY 25 0.0056
197 ACUTE RESPIRATORY DISTRESS SYNDROME 98 0.0055
198 HEPATITIS ACUTE 36 0.0055
199 SEPTIC SHOCK 237 0.0054
200 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 126 0.0054
201 HEPATOCELLULAR CARCINOMA 41 0.0054
202 HAEMOLYSIS 41 0.0053
203 BRONCHOPULMONARY ASPERGILLOSIS 40 0.0052
204 ENTERITIS 33 0.0052
205 PREMATURE DELIVERY 81 0.0051
206 INTERSTITIAL LUNG DISEASE 244 0.0050
207 LOW BIRTH WEIGHT BABY 40 0.0050
208 CHOLELITHIASIS 165 0.0050
209 BLOOD UREA INCREASED 84 0.0050
210 ESCHERICHIA INFECTION 41 0.0050
211 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 29 0.0049
212 ABNORMAL FAECES 40 0.0049
213 MULTI-ORGAN FAILURE 84 0.0049
214 BLOOD URIC ACID INCREASED 28 0.0048
215 BRONCHIOLITIS 17 0.0048
216 PROCTALGIA 31 0.0048
217 HYPERNATRAEMIA 24 0.0048
218 PANCREATITIS ACUTE 108 0.0048
219 BLOOD CREATININE DECREASED 15 0.0048
220 PREMATURE BABY 144 0.0048
221 PNEUMOCYSTIS JIROVECII PNEUMONIA 48 0.0048
222 MALNUTRITION 53 0.0047
223 TRANSAMINASES INCREASED 105 0.0047
224 B-CELL LYMPHOMA 16 0.0047
225 RESPIRATORY SYNCYTIAL VIRUS INFECTION 41 0.0047
226 CARDIAC FAILURE CHRONIC 20 0.0047
227 DUODENAL ULCER 33 0.0047
228 INTRACRANIAL PRESSURE INCREASED 26 0.0047
229 HYPOMAGNESAEMIA 64 0.0046
230 FIBROSIS 14 0.0045
231 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 23 0.0045
232 DIASTOLIC DYSFUNCTION 14 0.0045
233 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 34 0.0045
234 BLOOD MAGNESIUM DECREASED 39 0.0045
235 HEPATITIS 115 0.0045
236 PNEUMONIA BACTERIAL 41 0.0045
237 FOETAL GROWTH RESTRICTION 27 0.0044
238 SHOCK HAEMORRHAGIC 36 0.0044
239 VITAMIN D DEFICIENCY 43 0.0044
240 HEPATIC ENZYME INCREASED 300 0.0044
241 NON-SMALL CELL LUNG CANCER 21 0.0044
242 BLOOD PHOSPHORUS DECREASED 16 0.0044
243 AUTOIMMUNE HAEMOLYTIC ANAEMIA 15 0.0044
244 DRUG LEVEL BELOW THERAPEUTIC 24 0.0043
245 ATELECTASIS 42 0.0043
246 NEPHROGENIC ANAEMIA 20 0.0043
247 PLATELET COUNT DECREASED 457 0.0043
248 PULMONARY ALVEOLAR HAEMORRHAGE 24 0.0043
249 CHEILITIS 23 0.0042
250 SKIN PAPILLOMA 17 0.0042
251 NEUTROPHIL COUNT DECREASED 171 0.0042
252 ERYTHEMA MULTIFORME 39 0.0042
253 PROTHROMBIN TIME PROLONGED 25 0.0042
254 ENCEPHALOPATHY 102 0.0041
255 CLOSTRIDIUM DIFFICILE COLITIS 44 0.0041
256 CHOLECYSTITIS 49 0.0041
257 TUMOUR LYSIS SYNDROME 36 0.0041
258 COAGULOPATHY 68 0.0041
259 SEPSIS 455 0.0041
260 APLASIA PURE RED CELL 14 0.0041
261 PANCYTOPENIA 227 0.0041
262 PLEURAL EFFUSION 247 0.0041
263 YELLOW SKIN 19 0.0041
264 CARDIAC FAILURE ACUTE 27 0.0040
265 ACUTE MYELOID LEUKAEMIA 63 0.0040
266 DRUG LEVEL DECREASED 41 0.0040
267 AZOTAEMIA 16 0.0040
268 PERICARDIAL EFFUSION 92 0.0040
269 RHINITIS 32 0.0040
270 LYMPHOCYTE COUNT DECREASED 70 0.0040
271 KLEBSIELLA INFECTION 20 0.0040
272 ARTHRITIS BACTERIAL 16 0.0039
273 POST-TRAUMATIC STRESS DISORDER 26 0.0039
274 APHTHOUS ULCER 30 0.0039
275 BACTERIAL INFECTION 72 0.0039
276 FAECES SOFT 28 0.0038
277 PLATELET COUNT ABNORMAL 23 0.0038
278 ACUTE RESPIRATORY FAILURE 73 0.0038
279 INSURANCE ISSUE 58 0.0038
280 DERMATITIS ACNEIFORM 23 0.0038
281 ESCHERICHIA URINARY TRACT INFECTION 16 0.0038
282 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 19 0.0037
283 COMPRESSION FRACTURE 20 0.0037
284 AGRANULOCYTOSIS 69 0.0037
285 GASTROINTESTINAL INFLAMMATION 29 0.0037
286 CACHEXIA 19 0.0037
287 URINE OUTPUT DECREASED 32 0.0037
288 BOWEL MOVEMENT IRREGULARITY 28 0.0037
289 HEPATITIS B 22 0.0036
290 FOOD ALLERGY 28 0.0036
291 ENCEPHALITIS 25 0.0036
292 FREQUENT BOWEL MOVEMENTS 97 0.0036
293 ILEUS PARALYTIC 16 0.0036
294 DRUG ERUPTION 63 0.0036
295 TOXIC ENCEPHALOPATHY 18 0.0035
296 HAEMATEMESIS 90 0.0035
297 ACUTE HEPATIC FAILURE 48 0.0035
298 RESPIRATORY FAILURE 256 0.0035
299 PURPURA 31 0.0035
300 HEPATOTOXICITY 78 0.0035
301 DISEASE COMPLICATION 16 0.0035
302 TRANSPLANT REJECTION 28 0.0035
303 GASTROENTERITIS 51 0.0035
304 HYPOXIA 123 0.0035
305 HAEMORRHOIDAL HAEMORRHAGE 17 0.0035
306 EOSINOPHIL COUNT INCREASED 29 0.0035
307 PRURITUS 1335 0.0035
308 GASTRIC ULCER 66 0.0035
309 HEPATIC LESION 15 0.0035
310 ADRENAL INSUFFICIENCY 42 0.0035
311 LOCALISED OEDEMA 16 0.0035
312 PARTIAL SEIZURES 18 0.0034
313 RIGHT VENTRICULAR FAILURE 24 0.0034
314 HYPERTRIGLYCERIDAEMIA 20 0.0034
315 WRONG PRODUCT ADMINISTERED 23 0.0034
316 DEVICE RELATED INFECTION 52 0.0034
317 COLECTOMY 19 0.0034
318 GESTATIONAL DIABETES 16 0.0034
319 GASTROINTESTINAL INFECTION 30 0.0033
320 HYPOKALAEMIA 154 0.0033
321 SMALL INTESTINAL OBSTRUCTION 41 0.0033
322 STOMATITIS 202 0.0033
323 THROMBOCYTOPENIA 372 0.0033
324 SUSPECTED OFF LABEL USE 15 0.0033
325 MELAENA 73 0.0033
326 GENERALISED OEDEMA 41 0.0033
327 CLOSTRIDIUM DIFFICILE INFECTION 72 0.0033
328 NEPHROPATHY TOXIC 37 0.0033
329 HYPOTHYROIDISM 105 0.0033
330 FAILURE TO THRIVE 17 0.0033
331 SUBARACHNOID HAEMORRHAGE 33 0.0032
332 TACHYPNOEA 44 0.0032
333 CHROMATURIA 73 0.0032
334 LIVER FUNCTION TEST ABNORMAL 94 0.0032
335 RENAL IMPAIRMENT 270 0.0032
336 HYDRONEPHROSIS 24 0.0032
337 AUTOIMMUNE DISORDER 31 0.0032
338 IMMUNOSUPPRESSION 28 0.0032
339 HYPERTRANSAMINASAEMIA 22 0.0032
340 BLOOD CREATINE INCREASED 14 0.0032
341 MOUTH HAEMORRHAGE 23 0.0031
342 LIPASE INCREASED 24 0.0031
343 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 32 0.0031
344 PULMONARY TOXICITY 22 0.0031
345 MALABSORPTION 16 0.0031
346 NEPHROTIC SYNDROME 21 0.0031
347 OLIGURIA 19 0.0031
348 TUBULOINTERSTITIAL NEPHRITIS 57 0.0030
349 MATERNAL EXPOSURE DURING PREGNANCY 271 0.0030
350 UPPER GASTROINTESTINAL HAEMORRHAGE 51 0.0030
351 GASTROINTESTINAL SOUNDS ABNORMAL 15 0.0030
352 RENAL CYST 24 0.0030
353 ABDOMINAL TENDERNESS 15 0.0030
354 PYREXIA 1045 0.0030
355 MAJOR DEPRESSION 22 0.0030
356 MYOSITIS 27 0.0030
357 ATRIAL SEPTAL DEFECT 25 0.0030
358 ILEUS 37 0.0030
359 BRONCHIECTASIS 20 0.0030
360 HEPATIC STEATOSIS 55 0.0029
361 SCRATCH 31 0.0029
362 HYPERGLYCAEMIA 107 0.0029
363 COLITIS ULCERATIVE 131 0.0029
364 C-REACTIVE PROTEIN INCREASED 106 0.0029
365 GALLBLADDER DISORDER 52 0.0029
366 PRODUCT DISTRIBUTION ISSUE 27 0.0029
367 ALTERED STATE OF CONSCIOUSNESS 63 0.0029
368 RED BLOOD CELL COUNT DECREASED 83 0.0029
369 BLOOD POTASSIUM INCREASED 47 0.0029
370 FLANK PAIN 27 0.0029
371 HAEMATOCRIT DECREASED 57 0.0029
372 WEIGHT FLUCTUATION 30 0.0029
373 STAPHYLOCOCCAL INFECTION 94 0.0028
374 INFUSION SITE ERYTHEMA 24 0.0028
375 ELECTROLYTE IMBALANCE 33 0.0028
376 CHOLECYSTITIS CHRONIC 19 0.0028
377 BLOOD CREATININE INCREASED 185 0.0028
378 HAEMOPTYSIS 79 0.0028
379 PREMATURE LABOUR 16 0.0028
380 ACUTE KIDNEY INJURY 432 0.0028
381 ANAEMIA 538 0.0028
382 BLOOD CREATINE PHOSPHOKINASE INCREASED 81 0.0028
383 CHOLECYSTECTOMY 32 0.0028
384 HYPOCALCAEMIA 53 0.0028
385 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 17 0.0028
386 GINGIVITIS 15 0.0028
387 RENAL FAILURE ACUTE 118 0.0028
388 FAECES DISCOLOURED 60 0.0028
389 RALES 16 0.0028
390 RESPIRATORY DISTRESS 76 0.0028
391 PROTEINURIA 52 0.0027
392 LIVER INJURY 67 0.0027
393 EPSTEIN-BARR VIRUS INFECTION 17 0.0027
394 ABDOMINAL DISTENSION 284 0.0027
395 FLUID OVERLOAD 39 0.0027
396 WHITE BLOOD CELL COUNT DECREASED 289 0.0027
397 WHITE BLOOD CELL COUNT ABNORMAL 17 0.0027
398 TYPE 1 DIABETES MELLITUS 16 0.0027
399 OESOPHAGITIS 29 0.0027
400 PNEUMOTHORAX 42 0.0026
401 THERAPY INTERRUPTED 189 0.0026
402 MENTAL STATUS CHANGES 73 0.0026
403 FOETAL EXPOSURE DURING PREGNANCY 213 0.0026
404 HAEMODIALYSIS 22 0.0026
405 SKIN ATROPHY 15 0.0026
406 LARGE INTESTINE POLYP 18 0.0026
407 LARGE INTESTINE PERFORATION 18 0.0026
408 CEREBRAL HAEMORRHAGE 92 0.0026
409 APPENDICITIS 24 0.0026
410 DIARRHOEA HAEMORRHAGIC 24 0.0026
411 MITRAL VALVE INCOMPETENCE 29 0.0026
412 THERAPY CESSATION 131 0.0025
413 RENAL TUBULAR NECROSIS 25 0.0025
414 PULMONARY HYPERTENSION 53 0.0025
415 SPINAL COMPRESSION FRACTURE 21 0.0025
416 POSTOPERATIVE WOUND INFECTION 17 0.0025
417 RENAL FAILURE 334 0.0025
418 ABDOMINAL PAIN 584 0.0025
419 HAEMOGLOBIN DECREASED 257 0.0025
420 HAEMOGLOBIN ABNORMAL 16 0.0025
421 HEPATITIS C 30 0.0025
422 PNEUMONIA ASPIRATION 62 0.0025
423 PNEUMONIA 803 0.0025
424 DECREASED APPETITE 573 0.0025
425 INGUINAL HERNIA 15 0.0025
426 VIRAL INFECTION 82 0.0025
427 HERPES SIMPLEX 16 0.0025
428 BONE MARROW FAILURE 50 0.0025
429 COVID-19 PNEUMONIA 29 0.0025
430 THERAPY NON-RESPONDER 110 0.0024
431 EXPOSURE DURING PREGNANCY 152 0.0024
432 LOWER GASTROINTESTINAL HAEMORRHAGE 18 0.0024
433 HOSPICE CARE 24 0.0024
434 NEUTROPENIA 330 0.0024
435 PYELONEPHRITIS 21 0.0024
436 BLOOD TEST ABNORMAL 34 0.0024
437 PULMONARY ARTERIAL HYPERTENSION 35 0.0024
438 SINUS TACHYCARDIA 34 0.0024
439 TRICUSPID VALVE INCOMPETENCE 19 0.0024
440 INTESTINAL OBSTRUCTION 90 0.0024
441 TASTE DISORDER 48 0.0024
442 FULL BLOOD COUNT ABNORMAL 25 0.0024
443 BLOOD IRON DECREASED 28 0.0024
444 INFECTION 341 0.0024
445 MYOCARDITIS 27 0.0024
446 ACIDOSIS 18 0.0024
447 PRODUCT PRESCRIBING ERROR 56 0.0023
448 MATERNAL DRUGS AFFECTING FOETUS 18 0.0023
449 HAEMOLYTIC ANAEMIA 21 0.0023
450 NEUROTOXICITY 41 0.0023
451 METASTASES TO LUNG 27 0.0023
452 ANURIA 20 0.0023
453 RESPIRATION ABNORMAL 16 0.0023
454 CAESAREAN SECTION 27 0.0023
455 PETECHIAE 24 0.0023
456 HAEMATOCHEZIA 126 0.0023
457 PNEUMONITIS 62 0.0023
458 PULMONARY CONGESTION 30 0.0023
459 INTERNAL HAEMORRHAGE 26 0.0023
460 DEPRESSED LEVEL OF CONSCIOUSNESS 90 0.0023
461 INCONTINENCE 24 0.0023
462 CONCOMITANT DISEASE AGGRAVATED 14 0.0023
463 HYPONATRAEMIA 127 0.0023
464 HYPERKALAEMIA 79 0.0023
465 GASTROINTESTINAL HAEMORRHAGE 188 0.0022
466 STEVENS-JOHNSON SYNDROME 50 0.0022
467 END STAGE RENAL DISEASE 41 0.0022
468 INTERNATIONAL NORMALISED RATIO INCREASED 64 0.0022
469 DRUG LEVEL INCREASED 37 0.0022
470 VASCULITIS 26 0.0022
471 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 122 0.0022
472 METASTASES TO LYMPH NODES 15 0.0022
473 GASTROENTERITIS VIRAL 40 0.0022
474 INABILITY TO AFFORD MEDICATION 22 0.0022
475 OEDEMA PERIPHERAL 270 0.0022
476 OEDEMA 120 0.0022
477 EATING DISORDER 47 0.0022
478 BODY TEMPERATURE INCREASED 45 0.0022
479 ORAL CANDIDIASIS 29 0.0022
480 NEPHROLITHIASIS 101 0.0022
481 RHABDOMYOLYSIS 91 0.0022
482 PRODUCT ADMINISTRATION ERROR 44 0.0022
483 BLOOD SODIUM DECREASED 41 0.0022
484 SHOCK 50 0.0022
485 LABORATORY TEST ABNORMAL 64 0.0022
486 METASTASES TO LIVER 38 0.0022
487 FUNGAL INFECTION 72 0.0022
488 URINARY RETENTION 72 0.0022
489 EPISTAXIS 161 0.0022
490 POST PROCEDURAL HAEMORRHAGE 25 0.0021
491 ORAL PAIN 48 0.0021
492 DIARRHOEA 1381 0.0021
493 COLITIS 81 0.0021
494 PAPULE 15 0.0021
495 CEREBRAL INFARCTION 52 0.0021
496 PRURITUS GENERALISED 46 0.0021
497 RENAL DISORDER 99 0.0021
498 PEMPHIGOID 16 0.0021
499 OFF LABEL USE 1852 0.0021
500 ANAL INCONTINENCE 19 0.0021
501 RETINAL HAEMORRHAGE 15 0.0021
502 HYPERCALCAEMIA 26 0.0021
503 HOSPITALISATION 323 0.0021
504 CONSTIPATION 456 0.0021
505 GASTRIC HAEMORRHAGE 24 0.0021
506 WHITE BLOOD CELL COUNT INCREASED 80 0.0021
507 CANDIDA INFECTION 35 0.0021
508 HICCUPS 17 0.0021
509 PLATELET COUNT INCREASED 27 0.0021
510 BRAIN OEDEMA 26 0.0021
511 PELVIC FRACTURE 16 0.0021
512 DISEASE PROGRESSION 243 0.0021
513 THERAPY PARTIAL RESPONDER 32 0.0020
514 DYSPNOEA EXERTIONAL 77 0.0020
515 PULMONARY OEDEMA 91 0.0020
516 PRODUCTIVE COUGH 97 0.0020
517 SUBDURAL HAEMATOMA 29 0.0020
518 EAR INFECTION 53 0.0020
519 SUPRAVENTRICULAR TACHYCARDIA 19 0.0020
520 CELLULITIS 100 0.0020
521 POST PROCEDURAL COMPLICATION 38 0.0020
522 SKIN HYPERPIGMENTATION 17 0.0020
523 MYOPATHY 17 0.0020
524 CARDIAC FAILURE 157 0.0020
525 ABDOMINAL PAIN UPPER 401 0.0019
526 FLUID RETENTION 99 0.0019
527 ANOREXIA 25 0.0019
528 MYELODYSPLASTIC SYNDROME 28 0.0019
529 DEHYDRATION 258 0.0019
530 THERAPY CHANGE 19 0.0019
531 BLOOD POTASSIUM DECREASED 58 0.0019
532 SCAB 22 0.0019
533 NEPHROPATHY 18 0.0019
534 LUNG INFILTRATION 17 0.0019
535 HYPOPHAGIA 49 0.0019
536 DELIRIUM 66 0.0019
537 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21 0.0019
538 SKIN LESION 52 0.0019
539 METABOLIC ACIDOSIS 60 0.0019
540 MUSCULOSKELETAL CHEST PAIN 29 0.0019
541 RESPIRATORY DISORDER 56 0.0019
542 GLOMERULAR FILTRATION RATE DECREASED 23 0.0019
543 CARDIOMEGALY 23 0.0019
544 MOUTH ULCERATION 39 0.0018
545 RASH MACULO-PAPULAR 41 0.0018
546 SEASONAL ALLERGY 26 0.0018
547 POOR VENOUS ACCESS 19 0.0018
548 PANCREATITIS 97 0.0018
549 INFLUENZA 204 0.0018
550 BODY TEMPERATURE DECREASED 18 0.0018
551 FEEDING DISORDER 37 0.0018
552 MUSCLE ATROPHY 23 0.0018
553 NOCTURIA 22 0.0018
554 MYELOSUPPRESSION 65 0.0018
555 LUNG INFECTION 28 0.0018
556 LEUKAEMIA 17 0.0018
557 FLATULENCE 102 0.0018
558 LIVE BIRTH 15 0.0018
559 FULL BLOOD COUNT DECREASED 36 0.0018
560 INFUSION SITE PAIN 23 0.0018
561 ORTHOSTATIC HYPOTENSION 31 0.0018
562 OSTEOPENIA 27 0.0018
563 DRUG INTERACTION 280 0.0018
564 LIP DRY 16 0.0018
565 IMPAIRED GASTRIC EMPTYING 24 0.0018
566 HYPERLIPIDAEMIA 21 0.0018
567 VITAMIN D DECREASED 15 0.0018
568 ATRIAL FLUTTER 14 0.0018
569 HAEMATURIA 60 0.0018
570 GASTRITIS 46 0.0017
571 SKIN LACERATION 19 0.0017
572 BLOOD PRESSURE DECREASED 116 0.0017
573 GASTROINTESTINAL DISORDER 156 0.0017
574 BLOOD URINE PRESENT 33 0.0017
575 ASPIRATION 19 0.0017
576 INTERVERTEBRAL DISC DEGENERATION 16 0.0017
577 NO THERAPEUTIC RESPONSE 21 0.0017
578 BLOOD CALCIUM INCREASED 15 0.0017
579 WEIGHT DECREASED 475 0.0017
580 PREGNANCY 34 0.0017
581 BLOOD TRIGLYCERIDES INCREASED 30 0.0017
582 ULCER 27 0.0017
583 LYMPHADENOPATHY 60 0.0017
584 BLOOD PRESSURE SYSTOLIC INCREASED 33 0.0017
585 ORAL HERPES 33 0.0017
586 OXYGEN SATURATION DECREASED 95 0.0017
587 INCREASED APPETITE 32 0.0017
588 HYPOGLYCAEMIA 81 0.0017
589 PHARYNGITIS STREPTOCOCCAL 18 0.0017
590 GENERAL PHYSICAL HEALTH DETERIORATION 192 0.0017
591 LUNG DISORDER 81 0.0017
592 BONE PAIN 96 0.0016
593 COUGH 459 0.0016
594 VOMITING 763 0.0016
595 CARDIAC MURMUR 14 0.0016
596 SINUS DISORDER 32 0.0016
597 GINGIVAL BLEEDING 22 0.0016
598 NEURALGIA 39 0.0016
599 COVID-19 281 0.0016
600 HYPERTENSION 338 0.0016
601 PHOTOPHOBIA 30 0.0016
602 HYPERTHYROIDISM 23 0.0016
603 TOXIC SKIN ERUPTION 16 0.0016
604 BLOOD COUNT ABNORMAL 24 0.0016
605 PRODUCT AVAILABILITY ISSUE 36 0.0016
606 DISORIENTATION 62 0.0016
607 CONJUNCTIVITIS 29 0.0016
608 DRY EYE 78 0.0016
609 HYPOTENSION 313 0.0016
610 SINUS BRADYCARDIA 15 0.0016
611 HERNIA 30 0.0015
612 SKIN ULCER 40 0.0015
613 PULMONARY MASS 23 0.0015
614 HAEMATOMA 40 0.0015
615 IMMUNODEFICIENCY 23 0.0015
616 FACE OEDEMA 26 0.0015
617 INTENTIONAL PRODUCT USE ISSUE 135 0.0015
618 HAEMORRHOIDS 30 0.0015
619 DENTAL CARIES 17 0.0015
620 RECTAL HAEMORRHAGE 66 0.0015
621 PERIPHERAL COLDNESS 21 0.0015
622 GASTROOESOPHAGEAL REFLUX DISEASE 123 0.0015
623 WEIGHT INCREASED 342 0.0015
624 URINARY TRACT INFECTION 260 0.0015
625 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 73 0.0015
626 SECRETION DISCHARGE 19 0.0015
627 RHINORRHOEA 98 0.0015
628 HERPES ZOSTER 87 0.0015
629 FISTULA 17 0.0015
630 MIDDLE INSOMNIA 28 0.0015
631 CONDITION AGGRAVATED 451 0.0015
632 OROPHARYNGEAL PAIN 137 0.0015
633 DRUG RESISTANCE 38 0.0015
634 ABDOMINAL DISCOMFORT 248 0.0015
635 ECZEMA 77 0.0015
636 DIABETES MELLITUS 112 0.0015
637 HALLUCINATION, VISUAL 31 0.0015
638 CIRCULATORY COLLAPSE 25 0.0015
639 NEUTROPHIL COUNT INCREASED 15 0.0015
640 FATIGUE 1135 0.0015
641 PRODUCT DOSE OMISSION 95 0.0015
642 PHARYNGITIS 18 0.0014
643 INFUSION RELATED REACTION 96 0.0014
644 ERUCTATION 28 0.0014
645 DIZZINESS POSTURAL 14 0.0014
646 OBESITY 23 0.0014
647 IMMUNE SYSTEM DISORDER 19 0.0014
648 NEUROPATHY PERIPHERAL 137 0.0014
649 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
650 ANAPHYLACTIC SHOCK 37 0.0014
651 CHILLS 168 0.0014
652 ASTHENIA 536 0.0014
653 ABDOMINAL PAIN LOWER 36 0.0014
654 BLOOD CALCIUM DECREASED 16 0.0014
655 RESPIRATORY TRACT INFECTION 37 0.0014
656 DRUG WITHDRAWAL SYNDROME NEONATAL 21 0.0014
657 DIALYSIS 20 0.0014
658 BLOOD GLUCOSE ABNORMAL 26 0.0014
659 UPPER RESPIRATORY TRACT INFECTION 65 0.0014
660 BLOOD PRESSURE INCREASED 215 0.0014
661 BRAIN FOG 22 0.0014
662 NAUSEA 1108 0.0014
663 DRY MOUTH 113 0.0014
664 DECREASED ACTIVITY 15 0.0014
665 HIATUS HERNIA 18 0.0014
666 RASH PRURITIC 75 0.0014
667 PULMONARY THROMBOSIS 15 0.0014
668 BLOOD PRESSURE FLUCTUATION 33 0.0014
669 PRODUCT DOSE OMISSION ISSUE 404 0.0014
670 DIVERTICULITIS 38 0.0014
671 EOSINOPHILIA 24 0.0014
672 TOOTH EXTRACTION 17 0.0014
673 SLEEP DISORDER 96 0.0014
674 HEAD DISCOMFORT 24 0.0014
675 CARDIOMYOPATHY 20 0.0014
676 VENTRICULAR FIBRILLATION 15 0.0013
677 ATRIAL FIBRILLATION 131 0.0013
678 RASH 586 0.0013
679 LETHARGY 77 0.0013
680 HAEMORRHAGE INTRACRANIAL 20 0.0013
681 OSTEOPOROSIS 55 0.0013
682 INTESTINAL PERFORATION 15 0.0013
683 CARDIAC ARREST 110 0.0013
684 CONFUSIONAL STATE 215 0.0013
685 REBOUND EFFECT 15 0.0013
686 NEOPLASM PROGRESSION 46 0.0013
687 DYSPEPSIA 130 0.0013
688 ANAPHYLACTIC REACTION 73 0.0013
689 DISEASE RECURRENCE 62 0.0013
690 INTENTIONAL DOSE OMISSION 37 0.0013
691 TREATMENT NONCOMPLIANCE 71 0.0013
692 POLLAKIURIA 54 0.0013
693 MASS 18 0.0013
694 CYSTITIS 41 0.0013
695 TACHYCARDIA 114 0.0013
696 DYSPHONIA 75 0.0013
697 CONTUSION 123 0.0013
698 HIP FRACTURE 41 0.0013
699 DYSPHAGIA 121 0.0013
700 CYANOSIS 20 0.0013
701 PRODUCT DOSE OMISSION IN ERROR 36 0.0013
702 OSTEOMYELITIS 23 0.0013
703 LEUKOPENIA 63 0.0013
704 RASH ERYTHEMATOUS 60 0.0013
705 UPPER LIMB FRACTURE 25 0.0013
706 PRESCRIBED UNDERDOSE 25 0.0013
707 NASOPHARYNGITIS 231 0.0013
708 POLYNEUROPATHY 15 0.0013
709 CHEST DISCOMFORT 128 0.0012
710 HAEMORRHAGE 130 0.0012
711 ILLNESS 128 0.0012
712 METASTASES TO CENTRAL NERVOUS SYSTEM 16 0.0012
713 SKIN DISCOLOURATION 57 0.0012
714 MALIGNANT NEOPLASM PROGRESSION 127 0.0012
715 BRONCHITIS 91 0.0012
716 DERMATITIS CONTACT 14 0.0012
717 DYSURIA 45 0.0012
718 INFLAMMATION 63 0.0012
719 PRODUCT USE IN UNAPPROVED INDICATION 301 0.0012
720 DEVICE OCCLUSION 17 0.0012
721 PRODUCT USE ISSUE 227 0.0012
722 BLOOD CHOLESTEROL INCREASED 56 0.0012
723 SPINAL FRACTURE 24 0.0012
724 HEART RATE DECREASED 42 0.0012
725 PERIPHERAL SWELLING 184 0.0012
726 JOINT RANGE OF MOTION DECREASED 16 0.0012
727 PRESYNCOPE 29 0.0012
728 COLD SWEAT 21 0.0012
729 INSOMNIA 316 0.0012
730 CARDIOGENIC SHOCK 17 0.0012
731 CHRONIC KIDNEY DISEASE 90 0.0012
732 EAR PAIN 23 0.0012
733 SOMNOLENCE 235 0.0012
734 MALAISE 510 0.0012
735 RESPIRATORY ARREST 32 0.0012
736 LEUKOCYTOSIS 21 0.0012
737 PERITONITIS 24 0.0012
738 HYPERSOMNIA 33 0.0011
739 BRADYCARDIA 61 0.0011
740 MYALGIA 195 0.0011
741 CHEST PAIN 212 0.0011
742 MUSCULAR WEAKNESS 130 0.0011
743 CARPAL TUNNEL SYNDROME 16 0.0011
744 DYSARTHRIA 43 0.0011
745 BEDRIDDEN 15 0.0011
746 LYMPHOPENIA 16 0.0011
747 HEPATOCELLULAR INJURY 16 0.0011
748 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 29 0.0011
749 SEIZURE 130 0.0011
750 CARDIO-RESPIRATORY ARREST 47 0.0011
751 RESTLESSNESS 41 0.0011
752 BACK PAIN 259 0.0011
753 DEMENTIA 31 0.0011
754 ARTHRALGIA 460 0.0011
755 COMPLICATION ASSOCIATED WITH DEVICE 16 0.0011
756 HEART RATE INCREASED 109 0.0011
757 LYMPHOMA 17 0.0011
758 ARRHYTHMIA 52 0.0011
759 BONE DISORDER 20 0.0011
760 DYSSTASIA 32 0.0011
761 PAIN IN JAW 31 0.0011
762 EJECTION FRACTION DECREASED 17 0.0011
763 DYSPNOEA 618 0.0011
764 BASAL CELL CARCINOMA 17 0.0011
765 NASAL CONGESTION 64 0.0011
766 ANGIOEDEMA 48 0.0011
767 ELECTROCARDIOGRAM QT PROLONGED 39 0.0011
768 CONVULSION 62 0.0011
769 LACTIC ACIDOSIS 35 0.0011
770 DRUG EFFECT LESS THAN EXPECTED 16 0.0011
771 APHONIA 15 0.0011
772 FALL 356 0.0011
773 TYPE 2 DIABETES MELLITUS 36 0.0011
774 THROMBOSIS 86 0.0011
775 TOXICITY TO VARIOUS AGENTS 180 0.0011
776 PALLOR 29 0.0011
777 DIZZINESS 527 0.0011
778 HEADACHE 662 0.0011
779 FOOT FRACTURE 20 0.0011
780 SPEECH DISORDER 55 0.0010
781 TREMOR 174 0.0010
782 SINUSITIS 107 0.0010
783 LOWER LIMB FRACTURE 20 0.0010
784 OSTEOARTHRITIS 44 0.0010
785 METASTASES TO BONE 17 0.0010
786 RASH PAPULAR 23 0.0010
787 PSYCHOMOTOR HYPERACTIVITY 17 0.0010
788 SURGERY 60 0.0010
789 SKIN FISSURES 20 0.0010
790 RIB FRACTURE 21 0.0010
791 SKIN DISORDER 34 0.0010
792 PRODUCT USE COMPLAINT 16 0.0010
793 ALOPECIA 199 0.0010
794 CARDIAC FAILURE CONGESTIVE 81 0.0010
795 BLOOD PRESSURE ABNORMAL 20 0.0010
796 DRUG INTOLERANCE 97 0.0010
797 GOUT 18 0.0010
798 DERMATITIS 21 0.0010
799 FEMUR FRACTURE 31 0.0010
800 APHASIA 30 0.0010
801 SCAR 17 0.0010
802 LOCALISED INFECTION 24 0.0010
803 RETCHING 21 0.0010
804 EPILEPSY 30 0.0010
805 IRRITABLE BOWEL SYNDROME 21 0.0010
806 LOSS OF CONSCIOUSNESS 125 0.0010
807 MANIA 16 0.0010
808 VENTRICULAR TACHYCARDIA 16 0.0010
809 PULMONARY EMBOLISM 92 0.0010
810 CRYING 35 0.0010
811 NIGHT SWEATS 31 0.0010
812 ABNORMAL BEHAVIOUR 38 0.0010
813 DEAFNESS 25 0.0010
814 DEEP VEIN THROMBOSIS 62 0.0010
815 RESPIRATORY TRACT CONGESTION 15 0.0009
816 ABSCESS 15 0.0009
817 DEPRESSION 213 0.0009
818 SYNCOPE 93 0.0009
819 POOR QUALITY SLEEP 20 0.0009
820 ABORTION SPONTANEOUS 37 0.0009
821 LIMB INJURY 25 0.0009
822 KIDNEY INFECTION 18 0.0009
823 HEAD INJURY 29 0.0009
824 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 165 0.0009
825 ARTHRITIS 72 0.0009
826 ASTHMA 103 0.0009
827 RENAL INJURY 27 0.0009
828 DEATH 783 0.0009
829 ANXIETY 258 0.0009
830 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
831 EYE PAIN 51 0.0009
832 DIABETES MELLITUS INADEQUATE CONTROL 16 0.0009
833 BALANCE DISORDER 78 0.0009
834 THIRST 16 0.0009
835 SLEEP APNOEA SYNDROME 17 0.0009
836 PALPITATIONS 104 0.0009
837 DIPLOPIA 23 0.0009
838 HEMIPARESIS 15 0.0009
839 NEOPLASM MALIGNANT 59 0.0009
840 URINARY INCONTINENCE 26 0.0009
841 HEPATIC CANCER 21 0.0009
842 PAIN IN EXTREMITY 257 0.0009
843 PRODUCT PRESCRIBING ISSUE 19 0.0009
844 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
845 ADVERSE DRUG REACTION 78 0.0009
846 GAIT DISTURBANCE 166 0.0009
847 NERVOUS SYSTEM DISORDER 27 0.0009
848 MUSCLE SPASMS 158 0.0009
849 AMNESIA 56 0.0009
850 AGITATION 63 0.0009
851 BLOOD GLUCOSE DECREASED 41 0.0009
852 AGEUSIA 21 0.0008
853 GAIT INABILITY 28 0.0008
854 PROCEDURAL PAIN 23 0.0008
855 CATARACT 49 0.0008
856 ERYTHEMA 168 0.0008
857 SYSTEMIC LUPUS ERYTHEMATOSUS 29 0.0008
858 DEPRESSED MOOD 43 0.0008
859 MEMORY IMPAIRMENT 111 0.0008
860 FLUSHING 82 0.0008
861 DRY SKIN 106 0.0008
862 ILL-DEFINED DISORDER 48 0.0008
863 SKIN CANCER 17 0.0008
864 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 56 0.0008
865 WOUND 22 0.0008
866 MENTAL IMPAIRMENT 19 0.0008
867 MUSCLE TWITCHING 18 0.0008
868 HYPERSENSITIVITY 144 0.0008
869 PAIN 475 0.0008
870 TREATMENT FAILURE 64 0.0008
871 DISCOMFORT 47 0.0008
872 URTICARIA 129 0.0008
873 BLISTER 43 0.0008
874 FEELING ABNORMAL 183 0.0008
875 DRUG INEFFECTIVE 1005 0.0008
876 WHEEZING 45 0.0008
877 GASTRIC DISORDER 26 0.0008
878 VERTIGO 46 0.0008
879 NECK PAIN 42 0.0008
880 HYPOAESTHESIA 112 0.0007
881 LOWER RESPIRATORY TRACT INFECTION 34 0.0007
882 ACUTE MYOCARDIAL INFARCTION 22 0.0007
883 MUSCULOSKELETAL PAIN 39 0.0007
884 EYE PRURITUS 25 0.0007
885 RASH MACULAR 26 0.0007
886 UNEVALUABLE EVENT 56 0.0007
887 THROAT IRRITATION 33 0.0007
888 COMA 35 0.0007
889 IMPAIRED HEALING 24 0.0007
890 MUSCULOSKELETAL STIFFNESS 64 0.0007
891 BLOOD GLUCOSE INCREASED 137 0.0007
892 SWELLING 68 0.0007
893 DRUG DOSE OMISSION 120 0.0007
894 JOINT STIFFNESS 19 0.0007
895 SWELLING FACE 47 0.0007
896 JOINT SWELLING 87 0.0007
897 TINNITUS 33 0.0007
898 FEELING HOT 44 0.0007
899 HALLUCINATION 54 0.0007
900 MENTAL DISORDER 31 0.0007
901 HEART RATE IRREGULAR 16 0.0007
902 THROAT TIGHTNESS 19 0.0007
903 INJECTION SITE PRURITUS 47 0.0007
904 EYE DISORDER 23 0.0007
905 ANGINA PECTORIS 20 0.0007
906 EYE IRRITATION 40 0.0007
907 INFLUENZA LIKE ILLNESS 57 0.0007
908 MOOD SWINGS 22 0.0007
909 BLINDNESS 28 0.0007
910 ACCIDENTAL OVERDOSE 25 0.0007
911 FEELING COLD 19 0.0007
912 ANGER 23 0.0007
913 UNDERDOSE 49 0.0007
914 GASTRIC CANCER 17 0.0007
915 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 35 0.0007
916 MOBILITY DECREASED 48 0.0007
917 MOOD ALTERED 18 0.0007
918 FIBROMYALGIA 16 0.0007
919 RASH GENERALISED 17 0.0007
920 VISUAL IMPAIRMENT 81 0.0007
921 NERVOUSNESS 34 0.0007
922 THERAPEUTIC RESPONSE DECREASED 39 0.0006
923 THERAPEUTIC RESPONSE SHORTENED 21 0.0006
924 VISUAL ACUITY REDUCED 21 0.0006
925 OCULAR HYPERAEMIA 30 0.0006
926 MIGRAINE 60 0.0006
927 UNRESPONSIVE TO STIMULI 16 0.0006
928 AGGRESSION 31 0.0006
929 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
930 HYPOACUSIS 26 0.0006
931 THERAPEUTIC PRODUCT EFFECT DECREASED 27 0.0006
932 LIP SWELLING 20 0.0006
933 COGNITIVE DISORDER 28 0.0006
934 LACRIMATION INCREASED 18 0.0006
935 SKIN EXFOLIATION 50 0.0006
936 PLASMA CELL MYELOMA 23 0.0006
937 IRRITABILITY 35 0.0006
938 RHEUMATOID ARTHRITIS 66 0.0006
939 DISTURBANCE IN ATTENTION 31 0.0006
940 HYPERHIDROSIS 74 0.0006
941 ROAD TRAFFIC ACCIDENT 24 0.0006
942 DYSGEUSIA 42 0.0006
943 BURNING SENSATION 39 0.0006
944 VISION BLURRED 76 0.0006
945 PANIC ATTACK 20 0.0005
946 PARAESTHESIA 85 0.0005
947 DRUG EXPOSURE DURING PREGNANCY 18 0.0005
948 INJURY 37 0.0005
949 DYSKINESIA 21 0.0005
950 ACNE 38 0.0005
951 MYOCARDIAL INFARCTION 86 0.0005
952 CARDIAC DISORDER 46 0.0005
953 CEREBROVASCULAR ACCIDENT 83 0.0005
954 ADVERSE EVENT 45 0.0005
955 OSTEONECROSIS 16 0.0005
956 EYE SWELLING 18 0.0005
957 VAGINAL HAEMORRHAGE 21 0.0005
958 INJECTION SITE ERYTHEMA 60 0.0005
959 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
960 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
961 MOVEMENT DISORDER 15 0.0005
962 CONTRAINDICATED PRODUCT ADMINISTERED 14 0.0005
963 HOT FLUSH 33 0.0004
964 INTENTIONAL PRODUCT MISUSE 38 0.0004
965 INJECTION SITE MASS 16 0.0004
966 MEDICATION ERROR 24 0.0004
967 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 30 0.0004
968 LUNG NEOPLASM MALIGNANT 17 0.0004
969 SUICIDAL IDEATION 36 0.0004
970 PSORIASIS 50 0.0004
971 INCORRECT DOSE ADMINISTERED 87 0.0004
972 INJECTION SITE HAEMORRHAGE 30 0.0004
973 DERMATITIS ATOPIC 19 0.0004
974 INJECTION SITE PAIN 109 0.0004
975 PRODUCT SUBSTITUTION ISSUE 20 0.0003
976 DEVICE MALFUNCTION 24 0.0003
977 DRUG EFFECT DECREASED 18 0.0003
978 INJECTION SITE BRUISING 26 0.0003
979 ARTHROPATHY 18 0.0003
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 65 0.0003
981 NO ADVERSE EVENT 56 0.0003
982 INJECTION SITE SWELLING 22 0.0003
983 OVERDOSE 60 0.0003
984 INJECTION SITE REACTION 18 0.0003
985 EMOTIONAL DISTRESS 31 0.0003
986 DEVICE ISSUE 22 0.0002
987 SKIN BURNING SENSATION 16 0.0002
988 PRODUCT QUALITY ISSUE 30 0.0002
989 PROSTATE CANCER 15 0.0002
990 BREAST CANCER 17 0.0002
991 COMPLETED SUICIDE 14 0.0002
992 DRUG WITHDRAWAL SYNDROME 14 0.0002
993 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002